Ending the Vicious Cycle: How Stem Cells Can Treat Rheumatoid Arthritis

Sorry, no results.
Please try another keyword

Rheumatoid arthritis (RA) is a common chronic inflammatory disease that causes joint swelling, pain, and eventual destruction of cartilage and bone tissue. Around 1 in 100 adults worldwide suffers from RA, with women 2-3 times more likely to get it than men. Without proper treatment, over half of medium-severe RA patients used to become disabled and unable to work full-time. But recent advances like stem cell therapy provide new ways to control inflammation and prevent joint damage.

Current RA Medications Have Limitations

The main drugs used today to treat RA are:

  • Disease-modifying antirheumatic drugs (DMARDs) suppress the immune system to reduce swelling. The most common is methotrexate, but it has side effects like nausea, infections, and blood cell issues.
  • Glucocorticoids like prednisone directly block immune genes but also increase the risks of weight gain, high blood pressure, and diabetes.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) relieve pain by inhibiting inflammation enzymes yet do not slow cartilage breakdown.

30–50% of patients don’t respond well to standard DMARDs, so they need added biologic DMARDs, which block proteins driving inflammation. However, these biologics are very costly and raise the chances of infections, neurological problems, and even cancer. Across all meds, 15–40% of medium-severe cases build up resistance or can’t take side effects. This shows the need for safer, more affordable alternatives.

Mesenchymal Stem Cells Have Anti-Inflammatory Effects

Mesenchymal stem cells (MSCs) are progenitor cells that can multiply and turn into fat, cartilage, bone, and other tissues. Researchers now want to use MSCs to treat conditions like RA due to their ability to alter inflammatory and adaptive immune responses. When exposed to inflammatory signals from immune cells, MSCs take on an anti-inflammatory form. They can inhibit the activation and functions of various immune cells, including dendritic cells, macrophages, T cells, and B cells, through secreted factors.

Mesenchymal stem cells (MSCs) act as immune modulators, influencing inflammation and immune response. They can release calming signals like TGF-β and IL-10, activating regulatory cells to quell swelling. Additionally, molecules like IDO, PGE2, and NO dampen immune activity. Interestingly, MSCs can also stimulate the immune system by signaling other cells to join the fight. Ultimately, the surrounding environment dictates how MSCs impact immunity, playing a key role in maintaining healthy immune balance.

Animal Studies Support Using MSCs Against Rheumatoid Arthritis

Given their range of effects on inflammation, many animal studies have tested MSC therapy for RA using mouse models resembling human disease. MSCs from bone marrow, umbilical cords, fat tissue were transplanted via intravenous (IV), intraperitoneal (IP), or intra-articular (IA) injection into joints.

Overall, MSC treatment reduced swelling, cartilage/bone damage, and severity in arthritis models. It seemingly involves adjusting immune cell behavior. Interestingly, human umbilical cord stem cells yielded the best results with no apparent downsides. They toned down harmful inflammatory signals and promoted beneficial anti-inflammatory responses, potentially paving the way for future treatment options.

Clinical Trials Show MSC Therapy is Safe and Effective

Encouraged by animal studies, researchers have done clinical trials testing both patient-derived and donor-derived MSC therapy for RA patients not responding to standard medications. Eighteen trials occurred so far with nine completed and published currently. No concerning side effects happened with either MSC type. Patients getting MSCs displayed reduced blood inflammatory factors, symptom relief, and meaningful disease control lasting months after single or multiple injections.

In a major study, Chinese patients with challenging rheumatoid arthritis received special stem cells alongside standard medication. This combo lowered inflammation and boosted immune balance, offering significant symptom relief for months without needing repeat treatment. Even after years, benefits persisted, suggesting stem cells hold promise as a safe and powerful addition to current therapies for severe cases.

However, some limitations exist, like small patient numbers without placebo groups. Differences also remain between trials in cell sources, doses, and delivery methods. At least 1 million MSCs per kg of body weight after single/multiple doses seems necessary for good outcomes. Although pricey now, expanding protocols to more patients or enhancing cells could make costs competitive with standard medications.

Strategies to Improve MSC Therapy Potential

To boost results, researchers have tested techniques to increase the anti-inflammatory functions of MSCs:

  • Adding special white blood cells that help control the immune system, like ones that release a molecule that helps reduce inflammation, may work together with other cells to bring down swelling and pain in the joints and stop the disease from getting worse.
  • Growing stem cells in ball-shaped clumps increases the substances they release, like a molecule that protects tissues, an enzyme involved in inflammation, and a molecule involved in pain and inflammation, compared to growing them in flat layers.
  • Triggering sensors in stem cells that recognize harmful things also makes them better at calming inflammation and helping immune cells balance themselves.
  • Making stem cells ready for action by using less oxygen, blocking growth signals, or cleaning up their insides all help them calm inflammation in similar ways.
  • Giving stem cells a “heads-up” about harmful molecules like TNF-alpha and interleukin-1 beta (special messengers that cause swelling) before injecting them into the body helps them get ready to fight inflammation much sooner.

Combinations of cytokines and other stimulatory conditions listed above can have additive or synergistic effects to maximize therapeutic potential.

The Future is Bright for Stem Cell Therapy

In summary, mesenchymal stem cells can suppress inflammatory responses and joint damage in RA animal models as well as display feasibility, safety, and efficacy in early clinical trials with refractory RA patients. As treatment protocols expand to more patients, become standardized, and leverage new engineering techniques to enhance cells, MSC infusion promises an appealing, fresh option beyond current medications for conquering this chronic, disabling condition.

The Stem Cell Medical Center, located in Antigua, specializes in using umbilical cord tissue-derived MSCs to harness regenerative healing for various inflammatory and degenerative illnesses. Let us help you write a new story of hope and health. Contact our welcoming patient care team today to learn if our cutting-edge stem cell treatments are right for your difficult-to-treat rheumatoid arthritis.